Filing Details

Accession Number:
0001144204-14-027196
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-02 16:30:43
Reporting Period:
2014-04-30
Filing Date:
2014-05-02
Accepted Time:
2014-05-02 16:30:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
894158 Synthetic Biologics Inc. SYN Pharmaceutical Preparations (2834) 133808303
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1076653 H Steve Kanzer C/O Pharmainvestors, Llc
9045 La Fontana Blvd, Suite 238
Boca Raton FL 33434
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-04-30 5,003,025 $1.43 2,195,489 No 4 S Indirect By: Accredited Venture Capital, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Accredited Venture Capital, LLC
Footnotes
  1. Represents weighted average price per share for the toal number of shares sold. These shares were sold in multiple transactions at prices ranging from $2.01 to $1.25, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. Of these shares beneficially owned, 375,246 shares are owned directly by Mr. Kanzer and 1,820,243 shares are held indirectly in the name of Accredited Venture Capital, LLC.
  3. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC.